USFDA concludes inspection at Zydus’ Ahmedabad facility

hanuman

Active member
New-Project-2023-06-16T170917.470.jpg


The cGMP inspection concluded with nil observations

Zydus Lifesciences has announced that the group’s injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad, underwent USFDA inspection from 5th June to 13 June, 2023.

The cGMP inspection concluded with nil observations.

This signifies that the facility has met the standards set by the current Good Manufacturing Practices (GMP).

The GMP ensures that manufacturing processes and facilities are designed, monitored, and controlled effectively, guaranteeing the production of safe and effective products that meet quality standards.









The post
Please, Log in or Register to view URLs content!
appeared first on
Please, Log in or Register to view URLs content!
.
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock